QIM
INSY

Quantitative Investment Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Quantitative Investment Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-69,500
Closed -$879K – 918
2017
Q2 		$879K Buy
+69,500
New +$822K 0.01% 587
2015
Q3 		– Sell
-26,900
Closed -$966K – 835
2015
Q2 		$966K Buy
+26,900
New +$838K 0.15% 138

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantitative Investment Management's INSY Position: Q3 2017 in Review

Quantitative Investment Management sold out of Insys Therapeutics, Inc. (INSY) in Q3 2017, closing a stake of 69,500 shares — an estimated $879K sold.

Quantitative Investment Management first reported a position in INSY in Q2 2015 and held it in 2 quarters. The position peaked at $966K in Q2 2015. 116 funds tracked by Wall St. Rank hold INSY as of Q3 2017.

  • Quantitative Investment Management reported no remaining Insys Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Quantitative Investment Management sold 69,500 Insys Therapeutics, Inc. shares in Q3 2017, an estimated $879K.
  • Quantitative Investment Management first reported a position in Insys Therapeutics, Inc. in Q2 2015 and held it in 2 quarters.
  • Quantitative Investment Management's Insys Therapeutics, Inc. position peaked at $966K in Q2 2015.
  • 116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2017.

Based on Quantitative Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.